Goldman Sachs Group Inc. cut its position in Vitamin Shoppe, Inc (NYSE:VSI) by 18.2% during the first quarter, Holdings Channel reports. The fund owned 65,834 shares of the specialty retailer’s stock after selling 14,639 shares during the period. Goldman Sachs Group Inc.’s holdings in Vitamin Shoppe were worth $1,327,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. raised its stake in Vitamin Shoppe by 14.8% in the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after buying an additional 282,598 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its stake in Vitamin Shoppe by 6.8% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,910,081 shares of the specialty retailer’s stock worth $38,488,000 after buying an additional 122,445 shares during the last quarter. Olstein Capital Management L.P. raised its stake in Vitamin Shoppe by 22.9% in the first quarter. Olstein Capital Management L.P. now owns 802,133 shares of the specialty retailer’s stock worth $16,163,000 after buying an additional 149,338 shares during the last quarter. State Street Corp raised its stake in Vitamin Shoppe by 9.2% in the first quarter. State Street Corp now owns 721,483 shares of the specialty retailer’s stock worth $14,535,000 after buying an additional 60,575 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in Vitamin Shoppe by 3.8% in the first quarter. Ameriprise Financial Inc. now owns 574,091 shares of the specialty retailer’s stock worth $11,568,000 after buying an additional 20,859 shares during the last quarter.

Shares of Vitamin Shoppe, Inc (NYSE VSI) traded up 3.689% during mid-day trading on Thursday, hitting $6.325. The company had a trading volume of 843,980 shares. The company has a 50-day moving average price of $10.69 and a 200-day moving average price of $16.09. Vitamin Shoppe, Inc has a 1-year low of $6.00 and a 1-year high of $28.56. The company has a market capitalization of $146.51 million, a price-to-earnings ratio of 8.140 and a beta of 0.68.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the consensus estimate of $0.39 by $0.16. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The business had revenue of $304.84 million for the quarter, compared to analysts’ expectations of $314.74 million. During the same quarter in the prior year, the company posted $0.55 EPS. The business’s revenue for the quarter was down 8.4% on a year-over-year basis. On average, equities analysts anticipate that Vitamin Shoppe, Inc will post $1.24 EPS for the current year.

WARNING: This story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/10/vitamin-shoppe-inc-vsi-shares-sold-by-goldman-sachs-group-inc.html.

A number of analysts have commented on VSI shares. Barclays PLC reissued an “equal weight” rating and issued a $13.00 target price (down previously from $24.00) on shares of Vitamin Shoppe in a report on Sunday, May 14th. BidaskClub lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Gabelli lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Finally, Zacks Investment Research lowered Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a report on Saturday, May 13th. Two analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The stock has a consensus rating of “Hold” and an average target price of $21.50.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.